⌘K
t
GSK plc's Chief Scientific Officer and President, R&D, Dr H Barron, acquired 1,164.026 notional American Depositary Shares (ADSs) within their GSK Executive Supplemental Savings Plan account. The transaction took place on June 7, 2022, on the New York Stock Exchange. Each ADS was acquired at a price of $44.2500.
| Date | 9 Jun 2022 |
| Time | 16:28:40 |
| Category | Director/PDMR dealings |
| ID | 3773O |
GSK plc (the 'Company')
Transaction notification
|
1. |
Details of PDMR/person closely associated with them ('PCA') |
||||
|
a) |
Name |
Dr H Barron |
|||
|
b) |
Position/status |
Chief Scientific Officer and President, R&D |
|||
|
c) |
Initial notification/ amendment |
Initial notification |
|||
|
2. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||||
|
a) |
Name |
GSK plc |
|||
|
b) |
LEI |
5493000HZTVUYLO1D793 |
|||
|
3. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted |
||||
|
a) |
Description of the financial instrument |
American Depositary Shares ('ADSs')
ISIN: US37733W1053 |
|||
|
b) |
Nature of the transaction |
Acquisition of notional ADSs within Dr Barron's GSK Executive Supplemental Savings Plan account.
|
|||
|
c) |
Price(s) and volume(s) |
|
Price(s) |
Volume(s) |
|
|
|
$44.2500 |
1,164.026 |
|
||
|
|
|
|
|
||
|
d) |
Aggregated information
|
N/A (single transaction) |
|||
|
Aggregated volume Price |
|
||||
|
e) |
Date of the transaction |
2022-06-07 |
|||
|
f) |
Place of the transaction
|
New York Stock Exchange (XNYS)
|
|||